Peptides9 min read
Does more growth hormone explain better sleep with ipamorelin?
Growth hormone and sleep are connected, but the human evidence often quoted for ipamorelin comes from a different drug. Learn what was actually measured.
Read articleBlog
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Explore the articles
Find a topic you’re curious about and take a closer look.
Peptides9 min read
Semax nasal products: why the formulation is part of the evidence
Why Semax drops, sprays and injections cannot be assumed equivalent—and what animal absorption studies and laboratory testing actually establish.
Read article
Peptides9 min read
Survodutide liver endpoints: what would show meaningful clinical benefit?
Liver fat, biopsy activity and clinical complications answer different questions. Learn what survodutide studies establish—and which benefits need longer trials.
Read article
Peptides9 min read
Does BPC-157 need to be near an injury?
The studies behind BPC-157 do not establish a near-injury injection advantage in people. Route, tissue exposure and healing outcomes need separate comparisons.
Read article
Peptides9 min read
Humanin and memory: what the research has actually tested
Cell survival, mouse behavior, human genetics and blood markers contribute different pieces to Humanin’s memory research.
Read article
Peptides9 min read
Does KPV prevent cancer in people? The evidence gap behind the laboratory claims
A KPV study found benefits in one mouse model and no tumor reduction in another. Neither establishes cancer prevention in people.
Read article
Peptides9 min read
Do antibodies against cagrilintide necessarily mean treatment stops working?
Anti-drug antibodies were detected in cagrilintide research, but detection, neutralization and clinical loss of effect are different findings.
Read article
Peptides9 min read
Eloralintide and selective amylin agonism: what it means
Eloralintide's receptor preference is scientifically interesting. Human trials determine whether it translates into useful benefits.
Read article
Peptides8 min read
Does zenagamtide beat other weight-loss medicines? What the trials can tell us
Zenagamtide's early weight result is promising. Trial populations, duration, withdrawal and analysis explain why it cannot yet establish a ranking.
Read article
Peptides8 min read
Does ARA-290 pain improvement prove nerve regeneration?
Pain relief matters, but it cannot prove nerve regrowth. See what ARA-290 studies found in symptoms, corneal images, skin markers and function.
Read article
Peptides9 min read
What a longer kisspeptin treatment trial needs to show
Repeated kisspeptin studies help explain what comes next: sustained patient benefit, usable delivery, meaningful fertility outcomes and better safety follow-up.
Read article
Supplements9 min read
Chromium and blood sugar: what your starting health can tell you
Chromium trials differ by starting glucose control and treatment setting. Learn why this does not establish a chromium deficiency.
Read article470–481 of 600 articles